Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.

Also called NCT05337241

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Thermedical, Inc. (from the registry)
Registry
  • NCT NCT05337241
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05337241. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-09 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Condition
Refractory Ventricular Tachycardia
Intervention (Device)
Saline Enhanced Radiofrequency (SERF) Ablation
Lead sponsor
Thermedical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05337241
Content hash
8620e26721b683a8455b8fc71635669e651212c7a02365e2f8408e50c6c0885c